Publication
Neuropathological features of genetically confirmed DYT1 dystonia: Investigating disease-specific inclusions
Downloadable Content
- Persistent URL
- Last modified
- 02/20/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2014-01-27
- Publisher
- BioMed Central
- Publication Version
- Copyright Statement
- © 2014 Paudel et al.; licensee BioMed Central Ltd.
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 2051-5960
- Volume
- 2
- Issue
- 1
- Start Page
- 159
- End Page
- 159
- Grant/Funding Information
- Prof Jinnah is supported by grants from the NIH (NS 065701), private research foundations (Bachmann-Strauss Dystonia Parkinson’s Foundation and the Benign Essential Blepharospasm Research Foundation) and clinical studies grants from industry (Ipsen Pharmaceuticals, Merz Pharmaceuticals, Psyadon Pharmaceuticals).
- Prof Holton is supported by the Reta Lila Weston Institute for Neurological Studies, the Multiple System Atrophy Trust and Parkinson’s UK.
- This research was funded by grant NS 065701 to the Dystonia Coalition by the American National Institute of Neurological Disorders and Stroke and the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences, Impact Studentship UCL and supported by researchers at the National Institute for Health Research University College London Hospitals Biomedical Research Centre.
- Prof Bhatia is supported by Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, UCL.
- Dr Kiely is supported by the Multiple System Atrophy Trust. Dr Lashley is supported by Alzheimer’s Research UK. Prof Hardy reports no financial disclosure.
- Dr Bandopadhyay and Dr Li are supported by Reta Lila Weston Institute for Neurological Studies.
- Supplemental Material (URL)
- Abstract
- Introduction: Early onset isolated dystonia (DYT1) is linked to a three base pair deletion ((increment)GAG) mutation in the TOR1A gene. Clinical manifestation includes intermittent muscle contraction leading to twisting movements or abnormal postures. Neuropathological studies on DYT1 cases are limited, most showing no significant abnormalities. In one study, brainstem intraneuronal inclusions immunoreactive for ubiquitin, torsinA and lamin A/C were described. Using the largest series reported to date comprising 7 DYT1 cases, we aimed to identify consistent neuropathological features in the disease and determine whether we would find the same intraneuronal inclusions as previously reported. Result: The pathological changes of brainstem inclusions reported in DYT1 dystonia were not replicated in our case series. Other anatomical regions implicated in dystonia showed no disease-specific pathological intracellular inclusions or evidence of more than mild neuronal loss. Conclusion: Our findings suggest that the intracellular inclusions described previously in DYT1 dystonia may not be a hallmark feature of the disorder. In isolated dystonia, DYT1 in particular, biochemical changes may be more relevant than the morphological changes.
- Author Notes
- Keywords
- Research Categories
- Biology, Genetics
- Biology, Neuroscience
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - rz52g.pdf | Primary Content | 2025-02-18 | Public | Download |